Compound ID | 158
Synonym(s): TG-873870 (Taigexyn)
Class: Quinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor |
| Target Pathogen: | Active against vancomycin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, quinolone-resistant Staphylococcus aureus, quinolone-resistant Streptococcus pneumoniae, penicillin-resistant Streptococcus pneumoniae, and erythromycin-resistant Streptococcus pneumoniae |
| Description: | Synthetic compound; a novel non-fluorinated quinolone developed in oral and intravenous formulations; Cardiovascular Safety Evaluation of Nemonoxacin (TG-873870) in Dogs and Monkeys. . A-27. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. By: Chow, C. P.; Tsai, C. Y.; Chen, Y. M. |
| Institute where first reported: | TaiGen Biotechnology Co.,Taiwan |
| Year first mentioned: | 2007 |
| Highest development stage: | Approved in Taiwan |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11993740 |
| Guide to Pharmacology: | nemonoxacin |
| Citations: |
|